Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eli Lilly and Co (NYSE:LLY)

During the Trading Day
74.32 +0.04 / +0.05%
As of 4:02pm ET
Day’s Change
During After-Hours   Switch to standard view »
74.65 +0.3349 / +0.45%
Volume: 99.4K
String of Q4 Earnings Beat Fails to Revive Pharma ETFs
9:54am / Zacks.com
Fed in "Wait & See," Q4 Earnings Grind On
Jan 28 / Zacks.com
2 Numbers in Merck's 4th-Quarter Report That Have Investors Worried
Feb 04 / MotleyFool.com
Eli Lilly Tops on 4Q Earnings, Revenues, Maintains View
Jan 28 / Zacks.com
Novo Nordisk A/S Taps the Growth Brakes
Feb 04 / MotleyFool.com
Eli Lilly (LLY) Beats on Q4 Earnings & Revenues
Jan 28 / Zacks.com
ImmunoGen, Inc.'s Earnings Play the Amortization Blues
Feb 04 / MotleyFool.com
Johnson & Johnson's Newest Billion-Dollar Blockbuster
Jan 28 / MotleyFool.com
Hedge fund pioneer is force behind hotly tipped biotech companies
Feb 04 / FT.com
Here's the Case for and Against a MannKind Acquisition
Jan 27 / MotleyFool.com
Novo Nordisk lowers earnings targets as drug price pressure grows
Feb 03 / FT.com
A Billion-Dollar Drug? Maybe. But Lilly Will Have to Overcome This Roadblock First
Jan 26 / MotleyFool.com
3 Numbers That Matter When Merck Reports Its Fourth-Quarter Results
Feb 01 / MotleyFool.com
Will Lilly (LLY) Keep the Earnings Streak Alive in Q4?
Jan 26 / Zacks.com
Jim Cramer's Long-Term View on Health Care Stocks
Feb 01 / TheStreet.com
Celgene Reveals Data on Second-Line Abraxane-Gemzar
Jan 25 / Zacks.com
Forget Biosimilars: It's This Threat That Could Dent AbbVie's Top Line
Jan 31 / MotleyFool.com
Will Currency and Generics Hit J&J's (JNJ) Q4 Earnings?
Jan 25 / Zacks.com
Eli Lilly And Company (LLY) Earnings Report: Q4 2015 Conference Call Transcript
Jan 29 / TheStreet.com
Brexit would be a 'mistake', say global pharma leaders
Jan 24 / FT.com
Why Incyte's Shares Crashed 12% Today
Jan 28 / MotleyFool.com
Q4 Earnings Season Spotlights Growth Challenges
Jan 22 / Zacks.com
4 Reasons Why Johnson & Johnson Exploded Higher Following Its Q4 Earnings Release
Jan 28 / MotleyFool.com
Halozyme Gets $5M as AbbVie Begins Dosing in Humira Trial
Jan 22 / Zacks.com